PEREGRINE CAPITAL MANAGEMENT LLC – Iovance Biotherapeutics, Inc. Transaction History
PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:
$2.31M
portfolio value
PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.23% | -13.31K shares | -499K | $9.58 | 241.49K |
| Q2 2022 | share | Decrease | -1.15% | -2.96K shares | -1.47M | $11.04 | 254.81K |
| Q1 2022 | share | Increase | +2.35% | 5.92K shares | -516K | $16.65 | 257.77K |
| Q4 2021 | share | Increase | +22.36% | 46.01K shares | -268K | $19.42 | 251.85K |
| Q3 2021 | share | Decrease | -16.53% | -40.74K shares | -1.34M | $24.66 | 205.83K |
| Q2 2021 | share | Increase | +4.40% | 10.39K shares | -1.06M | $26.02 | 246.58K |
| Q1 2021 | share | Decrease | -12.27% | -33.04K shares | -5.01M | $31.66 | 236.18K |
| Q4 2020 | share | Decrease | -27.44% | -101.83K shares | 276K | $46.4 | 269.22K |
| Q3 2020 | share | Decrease | -8.69% | -35.33K shares | 1.06M | $32.92 | 371.06K |
| Q2 2020 | share | Increase | +7.11% | 26.98K shares | -202K | $27.45 | 406.40K |
| Q1 2020 | share | Decrease | -29.99% | -162.55K shares | -3.64M | $29.94 | 379.41K |
| Q4 2019 | share | Decrease | -15.77% | -101.43K shares | 3.29M | $27.68 | 541.97K |
| Q3 2019 | share | Decrease | -2.16% | -14.23K shares | -4.41M | $18.2 | 643.41K |
| Q2 2019 | share | Decrease | -20.91% | -173.86K shares | 8.21M | $24.52 | 657.65K |
| Q1 2019 | share | Increase | 0.00% | 831.51K shares | 7.90M | $9.51 | 831.51K |